ArticleClinical, cosmetic and investigational dermatology2025
The Comparable Efficacy Between Tranexamic Acid Intradermal Injection and Pulsed Dye Laser for Treatment of Post-Acne Erythema: A Split-Face Therapy.
Article in Clinical, cosmetic and investigational dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Effect of early application of a skin surface closure device combined with pulsed dye laser on the morphologic characteristics and clinical symptoms of tension scars on the backs of children.American journal of translational research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Post-acne erythema (PAE) is persistent erythema after acne vulgaris (AV) inflammatory lesions have resolved. Pulsed dye laser (PDL) is the gold standard for vascular lesions and is effective for PAE. Tranexamic acid (TA) can reduce vascular endothelial growth, angiogenesis, and inflammation by inhibiting plasminogen activity, and can be used in PAE treatment. This case report aim to compare the clinical efficacy of intradermal TA and PDL therapy using a split-face design in a 23-year-old female with moderate AV, post-inflammatory hyperpigmentation (PIH), and PEA. Dermatological examination revealed comedones, papules, pustules, nodules, hyperpigmented macules, boxcar scars, and erythematous macules overlying the post-acne atrophic scars. In addition to acne therapy, patient received intradermal TA (5 mg/mL) on the left face and PDL therapy on the right, respectively. Outcomes were assessed at day 7 and day 14. Parameters evaluated included acne lesion count, erythema index (a* value), and Dermatology Life Quality Index (DLQI). Both interventions led to a comparable result as such decreased a* value by 17.8% on the TA-treated side and 16% on the PDL-treated side. The DLQI score also improved. Both treatment modalities are effective for PAE and repeated sessions are necessary to achieve optimal results. Intradermal TA demonstrates comparable short-term efficacy to PDL in reducing PAE and may represent a safe, cost-effective alternative, particularly in resource-limited settings. Further studies with larger cohorts are needed to validate these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.